Showing results (171-180 of 205) with videos related to
Sort By:
Pageof 21
Cell Reports. Medicine|September 1, 2021
Compromised mitochondrial quality control triggers lipin1-related rhabdomyolysisYamina Hamel, François-Xavier Mauvais, Marine Madrange, et al.Frontiers in Immunology|April 5, 2018
Temporal Regulation of Natural Killer T Cell Interferon Gamma Responses by β-Catenin-Dependent and -Independent Wnt SignalingJessica C Kling, Margaret A Jordan, Lauren A Pitt, et al.Histopathology|July 26, 2017
New insights into naevoid melanomas: a clinicopathological reassessmentMartin G Cook, Daniela Massi, Willeke A M Blokx, et al.Rheumatology (Oxford, England)|February 12, 2021
JAK inhibitors are effective in a subset of patients with juvenile dermatomyositis: a monocentric retrospective studyTom Le Voyer, Cyril Gitiaux, François-Jérôme Authier, et al.The Journal of Investigative Dermatology|July 7, 2026
The genomic and spatial transcriptomic landscape of seborrheic keratosesHarald M Oey, Yung-Ching Kao, Katie J Lee, et al.Journal of Surgical Oncology|August 28, 2015
Prospective study of patterns of surgical management in adults with primary cutaneous melanoma at high risk of spread, in Queensland, AustraliaB Mark Smithers, Maria Celia B Hughes, Vanessa L Beesley, et al.Frontiers in Immunology|October 12, 2023
Targeting the chemokine receptor CXCR4 with histamine analog to reduce inflammation in juvenile arthritisNassima Bekaddour, Nikaïa Smith, Benoit Beitz, et al.Ebiomedicine|July 10, 2022
Objective assessment of tumor infiltrating lymphocytes as a prognostic marker in melanoma using machine learning algorithmsThazin Nwe Aung, Saba Shafi, James S Wilmott, et al.Rheumatology (Oxford, England)|May 24, 2025
Myositis-specific autoantibody subtypes are associated with response to Janus kinase inhibitors in patients with juvenile dermatomyositisBrigitte Bader-Meunier, Thomas R J Moreau, Florence Aeschlimann, et al.The Australasian Journal of Dermatology|August 6, 2025
Criteria for Commencing and Continuing Subsidised Janus Kinase Inhibitor Therapy in Australian Alopecia Areata Patients-Results From an Australian Expert Consensus ExerciseMeryl Thomas, Madeline Hankins, Emadodin Darchini-Maragheh, et al.Pageof 21